HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5257-5265

  Chung, Nancy P Y ^a   Matthews, Katie ^a   Klasse, Per Johan ^a   Sanders, Rogier W ^a,b   Moore, John P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; CD4 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CPG OLIGODEOXYNUCLEOTIDE; GLYCOPROTEIN GP 120; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; LECTIN RECEPTOR; MANNOSE BINDING C TYPE LECTIN RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANTIGENS, CD4; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL COMMUNICATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENE EXPRESSION; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; PRIMARY CELL CULTURE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84869795022     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201905     Document Type: Article

References (79)

1. Burton, D. R., R. C. Desrosiers, R. W. Doms, W. C. Koff, P. D. Kwong, J. P. Moore, G. J. Nabel, J. Sodroski, I. A. Wilson, and R. T. Wyatt. 2004. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5: 233-236. (Pubitemid 38332116)
2. Pantophlet, R., and D. R. Burton. 2006. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24: 739-769.
3. Klasse, P. J., R. W. Sanders, A. Cerutti, and J. P. Moore. 2012. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? AIDS Res. Hum. Retroviruses 28: 1-15.
4. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
5. Martinelli, E., C. Cicala, D. Van Ryk, D. J. Goode, K. Macleod, J. Arthos, and A. S. Fauci. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-αsecretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 104: 3396-3401. (Pubitemid 46364170)
6. Lambert, A. A., C. Gilbert, M. Richard, A. D. Beaulieu, and M. J. Tremblay. 2008. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 112: 1299-1307.
7. Gringhuis, S. I., J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T. B. Geijtenbeek. 2007. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26: 605-616. (Pubitemid 46756345)
8. Gringhuis, S. I., J. den Dunnen, M. Litjens, M. van der Vlist, and T. B. Geijtenbeek. 2009. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10: 1081-1088.
9. Gringhuis, S. I., M. van der Vlist, L. M. van den Berg, J. den Dunnen, M. Litjens, and T. B. Geijtenbeek. 2010. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 11: 419-426.
10. Shan, M., P. J. Klasse, K. Banerjee, A. K. Dey, S. P. Iyer, R. Dionisio, D. Charles, L. Campbell-Gardener, W. C. Olson, R. W. Sanders, and J. P. Moore. 2007. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 3: e169.
11. Banerjee, K., S. Andjelic, P. J. Klasse, Y. Kang, R. W. Sanders, E. Michael, R. J. Durso, T. J. Ketas, W. C. Olson, and J. P. Moore. 2009. Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology 389: 108-121.
12. Banerjee, K., E. Michael, D. Eggink, T. van Montfort, A. B. Lasnik, K. E. Palmer, R. W. Sanders, J. P. Moore, and P. J. Klasse. 2012. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice. AIDS Res. Hum. Retroviruses 28: 206-214.
13. He, B., X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti. 2006. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176: 3931-3941. (Pubitemid 44264370)
14. Kadowaki, N., and Y. J. Liu. 2002. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol. 63: 1126-1132. (Pubitemid 36025987)
15. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
16. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. (Pubitemid 32983021)
17. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198: 513-520. (Pubitemid 36976063)
18. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603. (Pubitemid 38481202)
19. Donaghy, H., A. Pozniak, B. Gazzard, N. Qazi, J. Gilmour, F. Gotch, and S. Patterson. 2001. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98: 2574-2576.
20. Pacanowski, J., S. Kahi, M. Baillet, P. Lebon, C. Deveau, C. Goujard, L. Meyer, E. Oksenhendler, M. Sinet, and A. Hosmalin. 2001. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98: 3016-3021.
21. Soumelis, V., I. Scott, F. Gheyas, D. Bouhour, G. Cozon, L. Cotte, L. Huang, J. A. Levy, and Y. J. Liu. 2001. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98: 906-912.
22. Kamga, I., S. Kahi, L. Develioglu, M. Lichtner, C. Marañón, C. Deveau, L. Meyer, C. Goujard, P. Lebon, M. Sinet, and A. Hosmalin. 2005. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J. Infect. Dis. 192: 303-310. (Pubitemid 40993400)
23. Patterson, S., A. Rae, N. Hockey, J. Gilmour, and F. Gotch. 2001. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75: 6710-6713. (Pubitemid 32578192)
24. Yonezawa, A., R. Morita, A. Takaori-Kondo, N. Kadowaki, T. Kitawaki, T. Hori, and T. Uchiyama. 2003. Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J. Virol. 77: 3777-3784. (Pubitemid 36297296)
25. Fonteneau, J. F., M. Larsson, A. S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78: 5223-5232. (Pubitemid 38581474)
26. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115: 3265-3275. (Pubitemid 41567591)
27. Reitano, K. N., S. Kottilil, C. M. Gille, X. Zhang, M. Yan, M. A. O'Shea, G. Roby, C. W. Hallahan, J. Yang, R. A. Lempicki, et al. 2009. Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res. Hum. Retroviruses 25: 1029-1037.
28. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234. (Pubitemid 37011337)
29. Poeck, H., M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2004. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103: 3058-3064. (Pubitemid 38451681)
30. Ding, C., Y. Cai, J. Marroquin, S. T. Ildstad, and J. Yan. 2009. Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner. J. Immunol. 183: 7140-7149.
31. Bekeredjian-Ding, I. B., M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann. 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174: 4043-4050. (Pubitemid 40395980)
32. Douagi, I., C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sörensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Loré. 2009. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J. Immunol. 182: 1991-2001.
33. Gujer, C., K. J. Sandgren, I. Douagi, W. C. Adams, C. Sundling, A. Smed-Sörensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Loré. 2011. IFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation. J. Leukoc. Biol. 89: 811-821.
34. Shaw, J., Y. H. Wang, T. Ito, K. Arima, and Y. J. Liu. 2010. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood 115: 3051-3057.
35. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
36. Tezuka, H., Y. Abe, J. Asano, T. Sato, J. Liu, M. Iwata, and T. Ohteki. 2011. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity 34: 247-257.
37. Krieg, A. M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5: 471-484. (Pubitemid 44136959)
38. Hennessy, E. J., A. E. Parker, and L. A. O'Neill. 2010. Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9: 293-307.
39. Mori, T., B. R. O'Keefe, R. C. Sowder, II, S. Bringans, R. Gardella, S. Berg, P. Cochran, J. A. Turpin, R. W. Buckheit, Jr., J. B. McMahon, and M. R. Boyd. 2005. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 280: 9345-9353. (Pubitemid 40409628)
40. O'Keefe, B. R., F. Vojdani, V. Buffa, R. J. Shattock, D. C. Montefiori, J. Bakke, J. Mirsalis, A. L. d'Andrea, S. D. Hume, B. Bratcher, et al. 2009. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc. Natl. Acad. Sci. USA 106: 6099-6104.
41. Moulaei, T., S. R. Shenoy, B. Giomarelli, C. Thomas, J. B. McMahon, Z. Dauter, B. R. O'Keefe, and A. Wlodawer. 2010. Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure 18: 1104-1115.
42. Alexandre, K. B., E. S. Gray, H. Mufhandu, J. B. McMahon, E. Chakauya, B. R. O'Keefe, R. Chikwamba, and L. Morris. 2012. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. Virology 423: 175-186.
43. Dai, J., N. J. Megjugorac, S. B. Amrute, and P. Fitzgerald-Bocarsly. 2004. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J. Immunol. 173: 1535-1548. (Pubitemid 38971583)
44. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
45. Cao, W., and Y. J. Liu. 2007. Innate immune functions of plasmacytoid dendritic cells. Curr. Opin. Immunol. 19: 24-30. (Pubitemid 46073695)
46. Fanning, S. L., T. C. George, D. Feng, S. B. Feldman, N. J. Megjugorac, A. G. Izaguirre, and P. Fitzgerald-Bocarsly. 2006. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J. Immunol. 177: 5829-5839. (Pubitemid 44628796)
47. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194: 1823-1834. (Pubitemid 34028661)
48. Kerkmann, M., S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner, A. Sarris, T. Giese, S. Endres, and G. Hartmann. 2003. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170: 4465-4474. (Pubitemid 36519951)
49. Meyer-Wentrup, F., D. Benitez-Ribas, P. J. Tacken, C. J. Punt, C. G. Figdor, I. J. de Vries, and G. J. Adema. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111: 4245-4253.
50. Hasan, U. A., E. Bates, F. Takeshita, A. Biliato, R. Accardi, V. Bouvard, M. Mansour, I. Vincent, L. Gissmann, T. Iftner, et al. 2007. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 178: 3186-3197. (Pubitemid 46333201)
51. Shiina, M., and B. Rehermann. 2008. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 47: 385-395. (Pubitemid 351280706)
52. Gondois-Rey, F., C. Dental, P. Halfon, T. F. Baumert, D. Olive, and I. Hirsch. 2009. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS ONE 4: e4319.
53. Xie, Q., H. C. Shen, N. N. Jia, H. Wang, L. Y. Lin, B. Y. An, H. L. Gui, S. M. Guo, W. Cai, H. Yu, et al. 2009. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect. 11: 515-523.
54. Xu, Y., Y. Hu, B. Shi, X. Zhang, J. Wang, Z. Zhang, F. Shen, Q. Zhang, S. Sun, and Z. Yuan. 2009. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol. Immunol. 46: 2640-2646.
55. Woltman, A. M., M. L. Op den Brouw, P. J. Biesta, C. C. Shi, and H. L. Janssen. 2011. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 6: e15324.
56. Hirsch, I., C. Caux, U. Hasan, N. Bendriss-Vermare, and D. Olive. 2010. Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends Immunol. 31: 391-397.
57. Sachdeva, N., V. Asthana, T. H. Brewer, D. Garcia, and D. Asthana. 2008. Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-alpha but not proinflammatory cytokines. J. Immunol. 181: 2887-2897.
58. Cerutti, A., X. Qiao, and B. He. 2005. Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol. Cell Biol. 83: 554-562. (Pubitemid 41805759)
59. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289. (Pubitemid 40692663)
60. Cerutti, A., I. Puga, and M. Cols. 2011. Innate control of B cell responses. Trends Immunol. 32: 202-211.
61. Chang, J. J., A. Lacas, R. J. Lindsay, E. H. Doyle, K. L. Axten, F. Pereyra, E. S. Rosenberg, B. D. Walker, T. M. Allen, and M. Altfeld. 2012. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS 26: 533-541.
62. Jiang, W., M. M. Lederman, R. J. Mohner, B. Rodriguez, T. M. Nedrich, C. V. Harding, and S. F. Sieg. 2008. Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection. J. Virol. 82: 7837-7845.
63. Klasse, P. J., and J. P. Moore. 2004. Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects? Virology 323: 1-8. (Pubitemid 38681015)
64. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309: 453-458. (Pubitemid 13041485)
65. De Milito, A. 2004. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res. 2: 11-21. (Pubitemid 38854921)
66. De Milito, A., A. Nilsson, K. Titanji, R. Thorstensson, E. Reizenstein, M. Narita, S. Grutzmeier, A. Sönnerborg, and F. Chiodi. 2004. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103: 2180-2186. (Pubitemid 38326236)
67. Moir, S., and A. S. Fauci. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9: 235-245.
68. Perisé-Barrios, A. J., M. A. Muñoz-Fernandez, and M. Pion. 2012. Direct phenotypical and functional dysregulation of primary human B cells by human immunodeficiency virus (HIV) type 1 in vitro. PLoS ONE 7: e39472.
69. Fantuzzi, L., C. Purificato, K. Donato, F. Belardelli, and S. Gessani. 2004. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J. Virol. 78: 9763-9772. (Pubitemid 39187094)
70. Chougnet, C., and S. Gessani. 2006. Role of gp120 in dendritic cell dysfunction in HIV infection. J. Leukoc. Biol. 80: 994-1000. (Pubitemid 44646305)
71. Weinhold, K. J., H. K. Lyerly, S. D. Stanley, A. A. Austin, T. J. Matthews, and D. P. Bolognesi. 1989. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142: 3091-3097. (Pubitemid 19129927)
72. Diamond, D. C., B. P. Sleckman, T. Gregory, L. A. Lasky, J. L. Greenstein, and S. J. Burakoff. 1988. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J. Immunol. 141: 3715-3717.
73. Oyaizu, N., N. Chirmule, V. S. Kalyanaraman, W. W. Hall, R. Pahwa, M. Shuster, and S. Pahwa. 1990. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87: 2379-2383.
74. Schols, D., and E. De Clercq. 1996. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J. Virol. 70: 4953-4960. (Pubitemid 26240663)
75. Berberian, L., L. Goodglick, T. J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261: 1588-1591. (Pubitemid 23319603)
76. Zouali, M. 1995. B-cell superantigens: implications for selection of the human antibody repertoire. Immunol. Today 16: 399-405.
77. Müller, S., and H. Köhler. 1997. B cell superantigens in HIV-1 infection. Int. Rev. Immunol. 14: 339-349. (Pubitemid 27210920)
78. Townsley-Fuchs, J., M. S. Neshat, D. H.Margolin, J. Braun, and L. Goodglick. 1997. HIV-1 gp120: a novel viral B cell superantigen. Int. Rev. Immunol. 14: 325-338. (Pubitemid 27210919)
79. Zhu, Q., C. Egelston, S. Gagnon, Y. Sui, I. M. Belyakov, D. M. Klinman, and J. A. Berzofsky. 2010. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J. Clin. Invest. 120: 607-616.